By Tony Schueth, CEO and Managing Partner
Changes are coming to electronic prescribing (ePrescribing) under Medicare Part D, as part of sweeping new legislation concerning the opioid epidemic that was signed into law on October 24. The new law is the “Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act’’ or the ‘‘SUPPORT for Patients and Communities Act” (aka HR6 and Public Law 115-271).
Among the Act’s dozens of treatment, prevention and enforcement provisions are two mandates for ePrescribing under Medicare Part D. They are:
Impacts. We see several potential impacts from these provisions, including:
What’s next? These mandates will advance use of health IT to positively impact provider workflow and efficiency. At the same time, some will substantially impact EHR and other technology roadmaps. Point-of-Care Partners is monitoring both legislative and implementation issues surrounding these mandates. For information on state and federal ePrescribing mandates and other requirements, contact Keith Fisher (email@example.com), who co-leads our Regulatory Resource Center (RRC). Stay tuned for future articles and blogs on implementation issues.
For more insights on how HR6 will impact ePrescribing, ePA and PDMPs, read our article in HIT Perspectives.
If you’d like to know more about the changing health IT landscape and what it means for your organization, drop me a line (firstname.lastname@example.org)